Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Surg. May 27, 2013; 5(5): 135-137
Published online May 27, 2013. doi: 10.4240/wjgs.v5.i5.135
Published online May 27, 2013. doi: 10.4240/wjgs.v5.i5.135
Prognosis and treatment of patients with positive peritoneal cytology in advanced gastric cancer
Francesco Frattini, Stefano Rausei, Corrado Chiappa, Francesca Rovera, Luigi Boni, Gianlorenzo Dionigi, Department of Surgical Sciences, University of Insubria School of Medicine, 21100 Varese, Italy
Author contributions: Frattini F collected the materials and wrote the manuscript; Rausei S, Chiappa C and Rovera F discussed the topic; Boni L and Dionigi G supervised the publication of this commentary.
Correspondence to: Francesco Frattini, MD, Department of Surgical Sciences, University of Insubria School of Medicine, Viale L. Borri 57, 21100 Varese, Italy. francescofrattini@virgilio.it
Telephone: +39-33-2278867 Fax: +39-33-2393630
Received: November 11, 2012
Revised: April 2, 2013
Accepted: April 18, 2013
Published online: May 27, 2013
Processing time: 166 Days and 22.9 Hours
Revised: April 2, 2013
Accepted: April 18, 2013
Published online: May 27, 2013
Processing time: 166 Days and 22.9 Hours
Core Tip
Core tip: Gastric cancer staging is still matter of debate as it evolves along with introduction of new diagnostic tools. Use of laparoscopy and washing cytology in gastric cancer staging has identified a particular category of patients with no macroscopic peritoneal disease but with positive peritoneal cytology. Prognosis and management of such patients still remains a controversial issue.